2 High-Flying Stocks to Consider Right Now and 1 That Underwhelm
3 Russell 2000 Stocks We Approach with Caution
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know
NeoGenomics, Inc. (NASDAQ: NEO) , a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the PanTracer™ LBx test has received coverage from the Centers...
3 Reasons to Avoid NEO and 1 Stock to Buy Instead
We estimate that MRD represents a $20+ billion addressable market, growing at 30% annually, which we believe is less than 10% penetrated
5 Insightful Analyst Questions From NeoGenomics’s Q4 Earnings Call
Why NeoGenomics (NEO) Shares Are Falling Today
NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the Company will participate in the following investor conferences:...
NEO Q4 Deep Dive: Product Mix Shift and Guidance Weigh on Outlook